Episode 8: AbCelleraem—AI Revolutionises Drug Discovery cover art

Episode 8: AbCelleraem—AI Revolutionises Drug Discovery

Episode 8: AbCelleraem—AI Revolutionises Drug Discovery

Listen for free

View show details

About this listen

AbCellera Biologics ($ABCL) is a technology company that has built a powerful, AI-powered engine to accelerate the discovery of new antibody-based medicines.1

Think of them as a high-tech "foundry" for the pharmaceutical industry. They partner with drugmakers, using their platform to rapidly screen millions of immune cells and pinpoint the most promising antibodies to fight diseases like cancer, autoimmune disorders, and infections.2

They are most famous for discovering the first authorized COVID-19 antibody therapy in a record-breaking 90 days, showcasing the immense speed and power of their technology. Their business model involves upfront fees, milestone payments, and long-term royalties on the sales of successful drugs they help discover.
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.